Yale Catriona

Akero Therapeutics, Inc. · Chief Development Officer

Yale Catriona is listed in filings as Chief Development Officer at Akero Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including sale activity. Recent filings connect the profile to Akero Therapeutics, Inc. (AKRO). The current snapshot covers public activity from Feb 21, 2025 to Dec 9, 2025. Reported amounts are shown as $3.6M to $2.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Akero Therapeutics, Inc.AKRO$458k8.7k sharesSellJul 16, 2025$52.87$54.65
Akero Therapeutics, Inc.AKRO$72k1.3k sharesSellJul 16, 2025$53.47$54.65
Akero Therapeutics, Inc.AKRO$90k1.6k sharesSellJun 18, 2025$54.84$54.65
Akero Therapeutics, Inc.AKRO$334k6.2k sharesSellJun 16, 2025$53.78$54.65
Akero Therapeutics, Inc.AKRO$159k2.9k sharesSellJun 16, 2025$54.80$54.65
Akero Therapeutics, Inc.AKRO$50k895 sharesSellJun 16, 2025$55.52$54.65
Akero Therapeutics, Inc.AKRO$151k2.8k sharesSellJun 10, 2025$54.00$54.65
Akero Therapeutics, Inc.AKRO$175k4.4k sharesSellMay 15, 2025$39.91$54.65
Akero Therapeutics, Inc.AKRO$110k2.8k sharesSellMay 15, 2025$39.46$54.65
Akero Therapeutics, Inc.AKRO$108k2.8k sharesSellMay 15, 2025$38.20$54.65
Akero Therapeutics, Inc.AKRO$298k7.9k sharesSellApr 15, 2025$37.80$54.65
Akero Therapeutics, Inc.AKRO$46k1.2k sharesSellApr 15, 2025$38.62$54.65
Akero Therapeutics, Inc.AKRO$367k8.2k sharesSellMar 17, 2025$44.70$54.65
Akero Therapeutics, Inc.AKRO$81k1.8k sharesSellMar 17, 2025$45.05$54.65
Akero Therapeutics, Inc.AKRO$28k614 sharesSellMar 12, 2025$44.88$54.65
Akero Therapeutics, Inc.AKRO$453k9.1k sharesSellFeb 18, 2025$49.79$54.65
Akero Therapeutics, Inc.AKRO$46k900 sharesSellFeb 18, 2025$50.63$54.65